NCT03926624 2026-01-22Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th SalvageDelta-Fly Pharma, Inc.Phase 3 Terminated167 enrolled
NCT00718549 2018-08-20A Study to Assess the Effect of Maintenance Treatment With Rituximab Versus No Treatment in Participants With Progressive B-Cell Chronic Lymphocytic Leukemia (CLL)Hoffmann-La RochePhase 3 Completed128 enrolled 10 charts